Aktienanalyse zu IDEXX Laboratories Inc (IDXX)IDXXIDEXX Laboratories Inc

IDEXX Laboratories, Inc. develops, manufactures, and distributes products and provides services primarily for the companion animal veterinary; livestock, poultry and dairy; and water testing industries. It also manufactures and sells human medical point-of-care diagnostic products. Its products and services include point-of-care veterinary diagnostic products, comprised of instruments, consumables, and rapid assay test kits. It also includes veterinary reference laboratory diagnostic and consulting services. It offers practice management systems, software and diagnostic imaging systems and services used by veterinarians. It also offers health monitoring, biological materials testing, laboratory diagnostic instruments, and services used by the biomedical research community. The Company provides diagnostic and health-monitoring products for livestock, poultry, and dairy; and products that test water for certain microbiological contaminants. It operates in the Healthcare sector (IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES industry).

IDEXX Laboratories Inc is a good buy right now due to its current price of $518, which is significantly lower than the average analyst price target of $670, indicating a potential upside of approximately 29%. Additionally, the company's forward P/E ratio of 31.45 suggests that it is trading at a reasonable valuation relative to its growth prospects, especially considering its recent earnings report that showed an EPS of 4.27, exceeding estimates by 8.10%.

10 analysts cover IDXX: 6 rate it Buy, 3 Hold and 1 Sell. The average price target is 792.78.